Work

HER2 in Uterine Serous Carcinoma: Testing platforms and implications for targeted therapy

Year: 2022

Type: article

Study design: Observational Study

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2022.09.006

Authors: Tenley R. Klc, Sharon Wu, Annelise M. Wilhite, Nathaniel L. Jones, Matthew A. Powell, Alex Olawaiye, Eugenia Girda, Jubilee Brown, Allison Puechl, Rouba Ali-Fehmi, Ira S. Winer, Thomas J. Herzog, W. Michael Korn, Britt K. Erickson

Institutions: University of Minnesota, Caris Life Sciences (United States), University of South Alabama, Washington University in St. Louis, University of Pittsburgh, Rutgers Cancer Institute, Levine Cancer Institute, Wayne State University, The Barbara Ann Karmanos Cancer Institute, University of Cincinnati

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: Eunice Kennedy Shriver National Institute of Child Health and Human Development

Award: G864505678

OpenAlex ID: W4295993497

FWCI: 1.715

Cites: 28

Cited by: 22

Related to: 10